Renaissance Technologies »

Atrium Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $201k 15k 13.45

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics